会计年度:2021-12-31收入分布
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 合计 | 10,384,575,260.66 | 6,702,615,506.38 | 3,681,959,754.28 | 35.46 | ||||
| 化学原料药 | 2,176,696,895.19 | 2,021,309,467.73 | 155,387,427.46 | 7.14 | ||||
| 化学制剂药 | 4,936,430,201.92 | 2,790,353,664.49 | 2,146,076,537.43 | 43.47 | ||||
| 其他 | 299,268,279.55 | 289,276,572.31 | 9,991,707.24 | 3.34 | ||||
| 其他(补充) | 80,195,163.23 | 42,635,185.69 | 37,559,977.54 | 46.84 | ||||
| 生物制剂 | 1,522,225,198.60 | 244,601,688.48 | 1,277,623,510.12 | 83.93 | ||||
| 医药及其它物流贸易 | 897,823,341.81 | 887,596,740.98 | 10,226,600.83 | 1.14 | ||||
| 医药中间体 | 471,936,180.36 | 426,842,186.70 | 45,093,993.66 | 9.56 | ||||
会计年度:2020-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 合计 | 11,492,504,163.48 | 7,306,845,958.45 | 4,185,658,205.03 | 36.42 | ||||
| 化学原料药 | 2,355,451,927.11 | 2,141,733,930.71 | 213,717,996.40 | 9.07 | ||||
| 化学制剂药 | 5,510,123,227.06 | 2,871,218,965.84 | 2,638,904,261.22 | 47.89 | ||||
| 其他 | 177,327,133.90 | 175,933,742.53 | 1,393,391.37 | 0.79 | ||||
| 其他(补充) | 62,019,689.10 | 22,318,143.74 | 39,701,545.36 | 64.01 | ||||
| 生物制剂 | 1,436,869,626.17 | 190,763,221.34 | 1,246,106,404.83 | 86.72 | ||||
| 医药及其他物流贸易 | 1,555,115,375.16 | 1,545,974,502.19 | 9,140,872.97 | 0.59 | ||||
| 医药中间体 | 395,597,184.98 | 358,903,452.10 | 36,693,732.88 | 9.28 | ||||
会计年度:2019-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 合计 | 10,880,767,824.24 | 6,287,855,536.77 | 4,592,912,287.47 | 42.21 | ||||
| 化学原料药 | 2,329,488,600.00 | 2,181,944,923.92 | 147,543,676.08 | 6.33 | ||||
| 化学制剂药 | 5,909,493,046.06 | 2,708,408,135.64 | 3,201,084,910.42 | 54.17 | ||||
| 其他 | 121,238,117.96 | 113,300,312.42 | 7,937,805.54 | 6.55 | ||||
| 其他(补充) | 57,027,307.05 | 16,536,583.93 | 40,490,723.12 | 71.00 | ||||
| 生物制剂 | 1,378,038,258.75 | 175,368,663.82 | 1,202,669,594.93 | 87.27 | ||||
| 医药及其它物流贸易 | 882,856,446.19 | 874,301,733.04 | 8,554,713.15 | 0.97 | ||||
| 医药中间体 | 202,626,048.23 | 217,995,184.00 | -15,369,135.77 | -7.58 | ||||
会计年度:2018-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 合计 | 9,213,775,284.29 | 5,326,660,807.98 | 3,887,114,476.31 | 42.19 | ||||
| 化学原料药 | 1,780,850,728.00 | 1,677,378,490.41 | 103,472,237.59 | 5.81 | ||||
| 化学制剂药 | 5,378,332,337.21 | 2,492,495,544.37 | 2,885,836,792.84 | 53.66 | ||||
| 其他 | 111,453,762.87 | 103,574,999.46 | 7,878,763.41 | 7.07 | ||||
| 其他(补充) | 82,907,568.40 | 12,132,008.67 | 70,775,559.73 | 85.37 | ||||
| 生物制剂 | 937,525,853.17 | 118,919,512.80 | 818,606,340.37 | 87.32 | ||||
| 医药及其它物流贸易 | 694,360,405.69 | 689,166,402.67 | 5,194,003.02 | 0.75 | ||||
| 医药中间体 | 228,344,628.95 | 232,993,849.60 | -4,649,220.65 | -2.04 | ||||
会计年度:2017-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 合计 | 7,636,184,998.21 | 5,229,954,690.80 | 2,406,230,307.41 | 31.51 | ||||
| 化学原料药 | 1,766,630,588.01 | 1,590,292,076.31 | 176,338,511.70 | 9.98 | ||||
| 化学制剂药 | 3,823,118,525.99 | 2,180,000,028.60 | 1,643,118,497.39 | 42.98 | ||||
| 其他 | 216,981,640.27 | 192,878,735.44 | 24,102,904.83 | 11.11 | ||||
| 生物制剂 | 652,003,985.69 | 94,015,748.16 | 557,988,237.53 | 85.58 | ||||
| 医药及其它物流贸易 | 1,058,702,582.59 | 1,049,121,986.26 | 9,580,596.33 | 0.90 | ||||
| 医药中间体 | 118,747,675.66 | 123,646,116.03 | -4,898,440.37 | -4.12 | ||||
1/8 转到 
违法和不良信息举报电话：010-85650899 传真：010-85650844 邮箱：yhts@staff.hexun.com
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号